Cargando…

Aspirin in the Food and Drug Administration Adverse Event Reporting System: Missing Demographics and Underreporting

Background The U.S. Food and Drug Administration (FDA) Adverse Event (AE) Reporting System (FAERS) is a global passive surveillance repository requiring mandatory updates by pharmaceutical manufacturers. Oral antiplatelet agents (OAAs) including aspirin (acetylsalicylic acid [ASA]) are broadly used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serebruany, Victor L., Tomek, Ales, Kim, Moo Hyun, Litvinov, Oleg, Marciniak, Thomas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2017
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524845/ https://www.ncbi.nlm.nih.gov/pubmed/31249915 http://dx.doi.org/10.1055/s-0037-1606301

Ejemplares similares

Assessing Cancer Signal during Oral Antiplatelet Therapy in the Food and Drug Administration Adverse Event Reporting System: Mission Impossible
por: Serebruany, Victor, et al.
Publicado: (2018)

Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting System
por: Serebruany, Victor, et al.
Publicado: (2017)

Bayesian Modeling for the Detection of Adverse Events Underreporting in Clinical Trials
por: Barmaz, Yves, et al.
Publicado: (2021)

Modelling underreported spatio-temporal crime events
por: Riascos Villegas, Álvaro J., et al.
Publicado: (2023)

Challenging the FDA Black Box Warning for High Aspirin Dose With Ticagrelor in Patients With Diabetes
por: DiNicolantonio, James J., et al.
Publicado: (2013)

Underreporting and Missed Opportunities for Uptake of Intermittent Preventative Treatment of Malaria in Pregnancy (IPTp) in Mali
por: Hurley, Emily A., et al.
Publicado: (2016)

COVID-19 in Africa: Underreporting, demographic effect, chaotic dynamics, and mitigation strategy impact
por: Thenon, Nathan, et al.
Publicado: (2022)

Factors associated with underreporting of adverse drug reactions by patients: a systematic review
por: Costa, Catarina, et al.
Publicado: (2023)

Erratum to: “Comparison of ACUITY, CRUSADE, and GRACE Risk Scales for Predicting Clinical Outcomes in Patients Treated with Dual-Antiplatelet Therapy”
por: Choi, Sun Young, et al.
Publicado: (2019)

Comparison of ACUITY, CRUSADE, and GRACE Risk Scales for Predicting Clinical Outcomes in Patients Treated with Dual-Antiplatelet Therapy
por: Choi, Sun Young, et al.
Publicado: (2018)

Cosmetics and Cancer: Adverse Event Reports Submitted to the Food and Drug Administration
por: Jacob, Saya L, et al.
Publicado: (2018)

Automatically Recognizing Medication and Adverse Event Information From Food and Drug Administration’s Adverse Event Reporting System Narratives
por: Polepalli Ramesh, Balaji, et al.
Publicado: (2014)

Incidental and Underreported Pleural Plaques at Chest CT: Do Not Miss Them—Asbestos Exposure Still Exists
por: Mazzei, Maria Antonietta, et al.
Publicado: (2017)

Corns in scleroderma: An underreported entity
por: Chathra, Namitha, et al.
Publicado: (2017)

Syphilis in Poland is on the rise and underreported
por: Teter, Zbigniew, et al.
Publicado: (2019)

Underreporting of COVID-19 deaths
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Assessment of Pertussis Underreporting in Italy
por: Bagordo, Francesco, et al.
Publicado: (2023)

Is concomitant aspirin helping novel oral anticoagulants? Focus on apixaban
por: DiNicolantonio, James J, et al.
Publicado: (2014)

Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
por: Toki, Tadashi, et al.
Publicado: (2018)

Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017
por: Dores, Graça M., et al.
Publicado: (2019)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
por: Liang, Yankun, et al.
Publicado: (2023)

CRUSADE Score is Superior to Platelet Function Testing for Prediction of Bleeding in Patients Following Coronary Interventions()
por: Bang, Junghee, et al.
Publicado: (2017)

Missed opportunities in aspirin prescribing for preeclampsia prevention
por: Singh, Noreen, et al.
Publicado: (2023)

Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration’s Adverse Event Reporting System from 2016 to 2021
por: Learned, Christine, et al.
Publicado: (2022)

Underreporting of Human Alveolar Echinococcosis, Germany
por: Jorgensen, Pernille, et al.
Publicado: (2008)

Paraovarian Cysts of Neoplastic Origin Are Underreported
por: Smorgick, Noam, et al.
Publicado: (2009)

Torsion of the Retroperitoneal Kidney: Uncommon or Underreported?
por: Sosin, Michael, et al.
Publicado: (2014)

Underreporting trends of occupational illnesses in Mexico
por: Moreno-Torres, Luis Antonio, et al.
Publicado: (2017)

Sexual abuse in males: An underreported issue
por: Juyal, Deepak, et al.
Publicado: (2017)

Ancestral Background Is Underreported in Regenerative Engineering
por: Ryan, Holly, et al.
Publicado: (2021)

Is suicide underreported? Evidence from Japan
por: Matsubayashi, Tetsuya, et al.
Publicado: (2021)

Prevention of adverse events in the administration of drugs
por: Diano, G, et al.
Publicado: (2010)

Underreporting of Fatal Congenital Zika Syndrome, Mexico, 2016–2017
por: Cardenas, Victor M., et al.
Publicado: (2019)

Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update
por: García-Abeijon, Patricia, et al.
Publicado: (2023)

Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System
por: Naganuma, Misa, et al.
Publicado: (2019)

Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019
por: Wei, Shaokui, et al.
Publicado: (2021)

Underreporting of Obesity in Hospital Inpatients: A Comparison of Body Mass Index and Administrative Documentation in Australian Hospitals
por: Di Bella, Alexandra L, et al.
Publicado: (2020)

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
por: Kato, Yamato, et al.
Publicado: (2015)

Retrospective analysis of adverse events with spironolactone in females reported to the United States Food and Drug Administration
por: Wang, Yu, et al.
Publicado: (2020)

Retrospective analysis of dermatologic adverse events associated with hydroxychloroquine reported to the US Food and Drug Administration
por: Lipner, Shari R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fmos9birdf7gbib0re57j2be9j